Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders. At the 2026 Annual Meeting of Stockholders (the "Meeting") of Treace Medical Concepts, Inc. (the "Company") held on May 19, 2026, the stockholders of the Company voted on the following proposals, each of which is described in the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 6, 2026.…
Filed May 20, 2026Accepted May 20, 2026, 5:30 PM EDTCIK 1630627Accession 0001630627-26-000014
Treace Medical Concepts, Inc. is a medical technology company with the goal of being the recognized leader in the surgical treatment of bunions and related deformities. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 67 million Americans, of which Treace estimates 1.1 million are annual surgical candidates. Treace has pioneered and patented the Lapiplasty® 3D Bunion Correction® System - a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. To further support the needs of surgeons and bunion patients, Treace offers its Adductoplasty® Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, two systems for
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 5.07Item 5.07 - Submission of Matters to Vote
Item 5.07.
Submission of Matters to a Vote of Security Holders.
At the 2026 Annual Meeting of Stockholders (the "Meeting") of Treace Medical Concepts, Inc. (the "Company") held on May 19, 2026, the stockholders of the Company voted on the following proposals, each of which is described in the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 6, 2026. The results of voting on the three proposals, including final voting tabulations, are set forth below.
Proposal 1: Election of Directors.
The stockholders elected, by the votes indicated below, the following nominees to the Company’s Board of Directors to serve as Class II directors for a three-year term of office expiring at the 2029 annual meeting of stockholders or until their respective successors have been duly elected and qualified:
Name For Withheld Broker Non-Vote
──────────────────────────────────────────────────────────────────────────
Lance A. Berry 33,804,407 820,723 13,516,432
Elizabeth S. Hanna 30,856,965 3,768,165 13,516,432
Jane E. Kiernan 33,587,226 1,037,904 13,516,432
Proposal 2: Advisory Vote on Executive Compensation.
By the vote stated below, the stockholders approved, on an advisory, non-binding basis, the compensation of the Company's named executive officers:
For Against Abstain Broker Non-Vote
───────────────────────────────────────────────────────────────
32,785,505 1,724,383 115,242 13,516,432
Proposal 3: Ratification of Selection of Independent Registered Public Accounting Firm.
By the vote stated below, the stockholders ratified the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026:
For Against Abstain Broker Non-Vote
─────────────────────────────────────────────────────────────
47,885,305 120,733 135,524 0